Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
FEATURED NOTICE | |
City of Spokane Valley Transportation Planning Services | |
New Bid Calls | 8 |
New Consultant Notices | 2 |
New Supply Bids | 1 |
2024 OLYMPIC REGION REGION WIDE CHIP SEAL Granite Construction Company |
SNOHOMISH REGIONAL FIRE & RESCUE 31 – SHOP ADDITION GENCAP Construction Corp. |
SR 169 & SR 509 FISH PASSAGE - WSDOT Kiewit Infrastructure West Co. |
EXPLORER MIDDLE SCHOOL, BID SET 2, BP 2.1, 4.1, 6.1, 7.1-2, 8.1, 9.1-3, 9.6-7 Cornerstone General Contractors |
EXPLORER MIDDLE SCHOOL, BID SET 2, BP-8.2 & 10.1 Cornerstone General Contractors |
more » |
print email to a friend reprints add to mydjc |
March 18, 2020
Philadelphia-based Century Therapeutics opened an innovation hub in Seattle to develop genetically engineered therapies for solid tumor cancers. The hub's goal is to overcome barriers that have limited the effectiveness of first-generation cell therapies. Dr. Hy Levitsky, Century's president of research and development, is overseeing the Seattle hub and collaborating with Dr. Luis Borges, Century's chief scientific officer at the Philadelphia headquarters. Levitsky has extensive biotech experience, previously as chief scientific officer at Juno Therapeutics in Seattle.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2024 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index